HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decompression for recurrent carpal tunnel syndrome provides significant functional improvement and patient satisfaction.

Abstract
This prospective single-centre study describes the functional outcomes, satisfaction and health-related quality of life after open revision carpal tunnel decompression for recurrent carpal tunnel syndrome. The QuickDASH, patient satisfaction and EuroQol-5 dimensions questionnaires were collected preoperatively and postoperatively over a 5-year period (2013-2018). The median time to revision was 13.3 years (range 3.9-35.4 years; interquartile range 7.2-15.9 years). Outcomes were available for 14 hands in 13 patients at a mean of 20 months after revision surgery. The mean preoperative and postoperative QuickDASH scores were 55 and 29, respectively, and the mean improvement in QuickDASH was 26. The mean improvement in EuroQol-5 dimensions score was 0.1, and 13 of the 14 patients were satisfied. The net promoter score was 85. This study confirms that patients undergoing revision open carpal tunnel decompression for recurrent carpal tunnel syndrome experience a significant improvement in function and health-related quality of life. Level of evidence: IV.
AuthorsPaul H C Stirling, Thomas F M Yeoman, Andrew D Duckworth, Nicholas D Clement, Paul J Jenkins, Jane E McEachan
JournalThe Journal of hand surgery, European volume (J Hand Surg Eur Vol) Vol. 45 Issue 3 Pg. 250-254 (Mar 2020) ISSN: 2043-6289 [Electronic] England
PMID31554451 (Publication Type: Journal Article)
Topics
  • Carpal Tunnel Syndrome (surgery)
  • Decompression, Surgical
  • Humans
  • Patient Satisfaction
  • Prospective Studies
  • Quality of Life
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: